Targeting p-FGFR1(Y654) Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8-CXCR2 Axis
靶向 p-FGFR1(Y654) 通过调节 CXCL8-CXCR2 轴增强 CD8+ T 细胞浸润并克服食管鳞状细胞癌的免疫治疗耐药性
期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines13071667
Luo, Hong; Wang, Liwei; Gao, Hui; Zhou, Daijun; Qiu, Yu; Yang, Lijia; Li, Jing; Du, Dan; Huang, Xiaoli; Zhao, Yu; Qi, Zhongchun; Zhang, Yue; Huang, Xuemei; Sun, Lihan; Xu, Tao; Li, Dong
CR2
CXCL8
肿瘤
T细胞
肿瘤免疫
治疗耐药
CD8
CXCR2
细胞生物学
FGFR1
免疫/内分泌